MedTrace Logo

Hematoma Block Versus Bier Block for Closed Fracture Reduction

NCT05086224 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2026-04-23

No results posted yet for this study

Summary

The investigators objective of this study is to evaluate the effectiveness of hematoma block versus intravenous regional anesthesia (Bier block) during closed reduction of distal radius fractures.

Conditions

  • Distal Radius Fractures

Interventions

DRUG

Bier Anesthetic Block Procedure with 1% Lidocaine

Intravenous anesthetic infusion, a maximum lidocaine dosing of 3 mg/kg.

DRUG

Hematoma Local Anesthetic Block Procedure with 1% Lidocaine

Inject anesthetic into the hematoma site, 20 mL of 1% lidocaine without epinephrine.

Sponsors & Collaborators

Principal Investigators

  • Lucas Marchand, MD · University of Utah Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2027-07-31
Completion
2027-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05086224 on ClinicalTrials.gov